ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 478

$583K Total Retail Price of All Prescriptions

Rank: 26 out of 478

306 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

41% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 5,285 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 904 325 S3 1 1
CARISOPRODOL 343 30 R 2 50
GABAPENTIN 309 75 3 8
FUROSEMIDE 291 195 4 6
OMEPRAZOLE 285 140 5 2
LISINOPRIL 273 162 6 3
ZOLPIDEM TARTRATE 267 86 7 16
NEXIUM 252 139 8 21
PRAVASTATIN SODIUM 226 156 9 11
SIMVASTATIN 199 127 10 5
RANITIDINE HCL 197 97 11 51
AMLODIPINE BESYLATE 194 124 12 4
HYDROCHLOROTHIAZIDE 178 81 13 10
PROAIR HFA 172 31 14 43
POTASSIUM CHLORIDE 170 99 15 19
FLUTICASONE PROPIONATE 151 40 16 39
METOPROLOL SUCCINATE 143 88 17 15
PROMETHAZINE HCL 131 27 R 18 72
ATORVASTATIN CALCIUM 125 44 19 12
CLOPIDOGREL 122 66 20 31
AMITRIPTYLINE HCL 120 50 R 21 53
METOPROLOL TARTRATE 117 82 22 14
LEVOTHYROXINE SODIUM 108 74 23 7
ENDOCET 104 63 S2 24 36
TAMSULOSIN HCL 95 94 25 48
RAMIPRIL 94 48 26 93
AMOXICILLIN 91 39 27 105
METFORMIN HCL ER 91 49 27 46
TIZANIDINE HCL 90 33 29 42
ATENOLOL 89 51 30 32
PLAVIX 89 46 30 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 61 32 18
METFORMIN HCL 83 41 33 9
GLIMEPIRIDE 81 35 34 55
ISOSORBIDE MONONITRATE ER 78 52 35 58
CLONIDINE HCL 75 35 36 61
ROPINIROLE HCL 70 45 37 103
FLUCONAZOLE 68 0 38 218
WARFARIN SODIUM 66 34 39 28
SINGULAIR 66 15 39 97
CYCLOBENZAPRINE HCL 63 20 R 41 35
AMLODIPINE BESYLATE-BENAZEPRIL 63 44 41 67
NITROSTAT 62 31 43 167
POLYETHYLENE GLYCOL 3350 62 33 43 62
FENTANYL 61 29 S2 45 27
OXYCODONE-ACETAMINOPHEN 59 45 S2 46 25
FAMOTIDINE 59 23 46 145
CRESTOR 59 58 46 22
MECLIZINE HCL 58 36 49 160
CARVEDILOL 57 35 50 24
BENAZEPRIL HCL 56 26 51 74
MELOXICAM 52 25 52 29
ZETIA 51 22 53 111
DIOVAN 50 23 54 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.